Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Now Available at ReportsandReports

DALLAS, September 2, 2010 - ReportsandReports announces it will carry the Epigenetics Therapeutics to
2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia,
Multiple Myeloma and Cutaneous T-Cell Lymphoma Market Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/epigenetics-therapeutics-to-2
017-high-market-potential-for-epig/

Search More Then 45000 Market Research Reports at ReportsandReports
(www.reportsandreports.com/)

GBI Research's report, "Epigenetics Therapeutics to 2017 - High Market
Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma
and Cutaneous T-Cell Lymphoma", provides in-depth analysis of trends, issues
and challenges in this industry. The report analyzes the technology that
shapes the industry dynamics for the key geographies: the US, the top five
countries in Europe (the UK, Germany, France, Italy and Spain) and Japan
(www.reportsandreports.com/). Further, the report provides competitive
benchmarking for the leading companies and analyzes the licensing agreements
that shape the global markets.

This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GBI
Research's team of industry experts.

    Scope

    The scope of this report includes:

    - Annualized market data from 2001 to 2009, forecast forward to 2016.
    - Analysis of the leading technology in this space
    - Market characterization
    - Key drivers and barriers that have a significant impact on the market.
    - Competitive benchmarking of leading companies.

    Reasons to buy

    The report will enhance your decision making capability. It will allow
    you to

    - Align your product portfolio to the markets with high growth potential.
    - Develop market-entry and market expansion strategies by identifying the
      leading therapeutic segments and geographic markets poised for strong
      growth.
    - Reinforce R&D pipelines
    - Develop key strategic initiatives by understanding the key focus areas
      of leading companies.
    - Exploit in-licensing and out-licensing opportunities by identifying
      products that could fill portfolio gaps.

    Table of Contents

    1.1 List of Tables 5
    1.2 List of Figures 6

    2 Introduction 7
    2.1 GBI Research Report Guidance 7

    3 Market Characterization: Global Epigenetics Market 8
    3.1 Disease Overview 8
    3.1.1 Myelodysplastic Syndrome 8
    3.1.2 Cutaneous T-cell Lymphoma 8
    3.2 Epigenetic Drugs 9
    3.3 The US 11
    3.4 Top Five European Markets 12
    3.5 Japan 14

    4 In-Depth Analysis 16
    4.1 Introduction 16
    4.2 Vidaza (Azacitidine) 16
    4.2.1 Indication 16
    4.2.2 Mechanism of Action 16
    4.2.3 Revenue Forecast 16
    4.2.4 Key Takeaway 23
    4.2.5 Market Potential 23
    4.2.6 Pipeline Analysis 29
    4.2.7 Drug Profile 32
    4.3 Dacogen (Decitabine) 33
    4.3.1 Indication 33
    4.3.2 Mechanism of action 33
    4.3.3 Revenue Forecast 34
    4.3.4 Key Takeaway 39
    4.3.5 Market Potential 39
    4.3.6 Pipeline Analysis 45
    4.3.7 Drug Profile 48
    4.4 Zolinza (Vorinostat) 49
    4.4.1 Indication 49
    4.4.2 Mechanism of Action 49
    4.4.3 Revenue Forecast 49
    4.4.4 Disease Overview 55
    4.4.5 Market Potential 55
    4.4.6 Pipeline Analysis 61
    4.4.7 Drug Profile 63
    4.5 Istodax (Romidepsin) 64
    4.5.1 Indication 64
    4.5.2 Disease Overview 64
    4.5.3 Mechanism of Action 65
    4.5.4 Market Potential 65
    4.5.5 Pipeline Analysis 71
    4.5.6 Clinical Studies by Phases 71
    4.5.7 Clinical Studies by Indication 72
    4.5.8 Drug Profile 73

    5 Competitive Landscape 75
    5.1 Merck & Co. 75
    5.1.1 Company Overview 75
    5.1.2 Business Description 75
    5.1.3 SWOT 77
    5.2 Celgene Corporation 77
    5.2.1 Company Overview 77
    5.2.2 Business Description 78
    5.2.3 SWOT 79
    5.3 EISAI 80
    5.3.1 Company Overview 80
    5.3.2 Business Description 80
    5.3.3 SWOT 82

    6 Epigenetic Therapeutics: Appendix 83
    6.1 Market Definitions 83
    6.2 Abbreviations 83
    6.3 Research Methodology 84
    6.3.1 Coverage 85
    6.3.2 Secondary Research 85
    6.3.3 Primary Research 85
    6.3.4 Forecasts 86
    6.3.5 Expert Panel Validation 88
    6.4 Contact Us 88
    6.5 Disclaimer 88
    6.6 Sources 88

Read Full TOC of Report :
www.reportsandreports.com/market-reports/epigenetics-therapeutics-to-2
017-high-market-potential-for-epig/

Browse all Pharmaceuticals Reports at
www.reportsandreports.com/market-research/pharmaceuticals/

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if one exists.)

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    www.reportsandreports.com/
    reportsnreports.wordpress.com/
    reportsandreports.blogspot.com/

Contact: Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004